$VRTX.d
Vertex Pharmaceuticals is a global biotechnology company that discovers and develops small-molecule drugs for the treatment of serious diseases. Its key drugs are Kalydeco, Orkambi, Symdeko, and Trikafta/Kaftrio, and Alyftrek for cystic fibrosis, where Vertex therapies remain the standard of care globally. Vertex has diversified its portfolio through Casgevy, a gene-editing therapy for beta thalas...
Stocks
$1.45
$484
▼0.33%from 30d ago
1
$0.00
Tokenized Stock Metrics
Metric
Show % of Total
Market Cap by Network
as of 08/18/2026
Key Facts
Name
Vertex Pharmaceuticals Incorporated Common Stock
Ticker
VRTX.d
CUSIP
—
ISIN
—
Platform
Tokenization Type
Type
—
Manager
—
Asset Class
Underlying Assets
—
Eligible Investors
Inception Date
—
Use Of Income
—
Management Fees
0%
Performance Fees
0%
Market Data
Total Value
$1
△
NAV
$484
▼
Price
—
Token Supply
0.00
△
Circulating Supply
0.00
△
7D APY
—
30D APY
—
Holders
1
△
Trailing 30D Active Addresses
—
Monthly Transfer Count
0
△
Monthly Transfer Volume
$0
△
Tokens
Primary Market
Eligible Investors
—
Base Assets
—
Subscription Time
—
Min. Investment
—
Subscription Fees
0%
Subscription Description
—
Redemption Time
—
Minimum Redemption Amount
—
Redemption Fees
0%
Redemption Description
—
KYC Description
—
Service Providers
Platform
Manager
—
Sub-Advisor
—
Custodian
Legal Identifier
—
Crypto Custodian
—
Fund Administrator
—
Traditional Broker
—
Crypto Broker
—
Auditor
—
Transfer Agent
—
Paying Agent
—
Legal & Regulatory
Issuer
Dinari
Issuer LEI
—
Issuer CIK
Domicile
United States of America
Regulatory Framework
U.S. Securities Act Reg. S Exemption
Dispute Resolution Country
—
Account Segregation
—
Bankruptcy Remote
—
Deposit Insurance
—
Terms
—
Fees
Management Fees
0%
Performance Fees
0%
Other Fees
—
Redemption Fees
0%
Subscription Fees
0%
RWA.xyzAll Rights Reserved